-
By Lee Spears, Bloomberg |
March 29, 2013
Pfizer, Goldman Sachs are among the companies selling businesses amid the stock market rally.
-
By David Welch, Aaron Kirchfeld and Matthew Monks, Bloomberg |
March 28, 2013
Dealmaking on track for worst month in more than three years.
-
By Christine Idzelis, Bloomberg |
March 28, 2013
Fed and other regulators are warning the market may be frothy.
-
By Tom Schoenberg and Andrew Zajac, Bloomberg |
March 20, 2013
Manipulation of rate may have cost Freddie and Fannie $3 billion, report says.
-
By Christie Smythe, Bloomberg |
March 6, 2013
Setting the rate isn’t a competitive process, they argue in court.
-
By Lee Spears, Jodi Xu and Jeffrey McCracken, Bloomberg |
February 15, 2013
Transaction volume has grown 27% so far this year.
-
By Alexis Leondis and Lisa Abramowicz |
January 22, 2013
Shift from market-size benchmarks may raise borrowing costs for industrialized nations.
-
By Joshua Gallu and Hans Nichols, Bloomberg |
January 18, 2013
Mary Jo White, now a partner at Debevoise & Plimpton, is being considered to succeed Elisse Walter.
-
By Jesse Hamilton, Bloomberg |
January 7, 2013
JPMorgan Chase, Bank of America and Citi among banks involved in settlement.
-
By Silla Brush, Bloomberg |
January 4, 2013
Financial institutions may get until 2015 to comply with Dodd-Frank rules about separating trades.